On January 17, 2025, the United States Patent and Trademark Office (“USPTO”) published a request for written comments on a recently adopted treaty....more
Precedential and Key Federal Circuit Opinions -
TEVA BRANDED PHARMACEUTICAL PRODUCTS R&D, INC. v. AMNEAL PHARMACEUTICALS OF NEW YORK, LLC [OPINION] (2024-1936, 12/20/2024) (Prost, Taranto, Hughes) -
Prost, J. The...more
1/27/2025
/ Intellectual Property Protection ,
Inter Partes Review (IPR) Proceeding ,
Novartis ,
Orange Book ,
Patent Infringement ,
Patent Litigation ,
Patent Trial and Appeal Board ,
Patents ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Precedential Opinion ,
Samsung ,
Teva Pharmaceuticals
This is the fourth issue of WilmerHale’s FRAND Quarterly: Navigating the Global SEP Landscape, a bulletin that highlights developments about the licensing, litigation, and regulation of patents that are or are claimed to be...more
12/19/2024
/ Antitrust Litigation ,
AT&T Mobility ,
Calculation of Damages ,
Ericsson ,
EU ,
FRAND ,
Intellectual Property Protection ,
IP License ,
Lenovo ,
Microsoft ,
Motorola ,
NVIDIA ,
Panasonic ,
Patent Litigation ,
Patents ,
Preliminary Injunctions ,
Qualcomm ,
Standard Essential Patents ,
UK ,
ZTE
Following nearly twenty-five years of negotiations, members of the World Intellectual Property Organization (WIPO) recently adopted a treaty implementing the new requirement for international patent applicants to disclose in...more